GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Granules India Ltd (NSE:GRANULES) » Definitions » Capex-to-Operating-Income

Granules India (NSE:GRANULES) Capex-to-Operating-Income : 0.00 (As of Dec. 2023)


View and export this data going back to 2005. Start your Free Trial

What is Granules India Capex-to-Operating-Income?

Capex-to-Operating-Income measures a company's investments in physical assets such as property, industrial buildings or equipment to its operating income.

Granules India's Capital Expenditure for the three months ended in Dec. 2023 was ₹0.00 Mil. Its Operating Income for the three months ended in Dec. 2023 was ₹1,980.89 Mil.

Hence, Granules India's Capex-to-Operating-Income for the three months ended in Dec. 2023 was 0.00.


Granules India Capex-to-Operating-Income Historical Data

The historical data trend for Granules India's Capex-to-Operating-Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Granules India Capex-to-Operating-Income Chart

Granules India Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Capex-to-Operating-Income
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.00 0.43 0.38 0.69 0.56

Granules India Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Capex-to-Operating-Income Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Granules India's Capex-to-Operating-Income

For the Drug Manufacturers - Specialty & Generic subindustry, Granules India's Capex-to-Operating-Income, along with its competitors' market caps and Capex-to-Operating-Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Granules India's Capex-to-Operating-Income Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Granules India's Capex-to-Operating-Income distribution charts can be found below:

* The bar in red indicates where Granules India's Capex-to-Operating-Income falls into.



Granules India Capex-to-Operating-Income Calculation

Granules India's Capex-to-Operating-Income for the fiscal year that ended in Mar. 2023 is calculated as

Capex-to-Operating-Income=- Capital Expenditure / Operating Income
=- (-4106.77) / 7376.97
=0.56

Granules India's Capex-to-Operating-Income for the quarter that ended in Dec. 2023 is calculated as

Capex-to-Operating-Income=- Capital Expenditure / Operating Income
=- (0) / 1980.89
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Granules India  (NSE:GRANULES) Capex-to-Operating-Income Explanation

Capex-to-Operating-Income assesses how much emphasis a company is placing upon investing in capital-intensive projects. The ratio is generally a good gauge to quantify how much focus on growth a company has. Typically, smaller companies that are still growing and expanding will have a higher Capex to Operating Income Ratio, since such businesses are likely investing more in physical assets. Lower ratios could indicate that a company has reached maturity and it is no longer pursuing aggressive growth.


Granules India Capex-to-Operating-Income Related Terms

Thank you for viewing the detailed overview of Granules India's Capex-to-Operating-Income provided by GuruFocus.com. Please click on the following links to see related term pages.


Granules India (NSE:GRANULES) Business Description

Traded in Other Exchanges
Address
3rd Block, My Home Hub, 2nd Floor, Madhapur, Hyderabad, TG, IND, 500 081
Granules India Ltd is an India-based pharmaceutical company. The company manufactures active pharmaceutical ingredients, pharmaceutical formulation intermediates and finished dosages. Its business is organized into three areas; the Core business which comprises core molecules such as Paracetamol, Ibuprofen, Metformin, Guaifenesin, and Methocarbamol; the Emerging business that focuses on manufacturing APIs and the US Generics. It has one segment Pharmaceutical products including ingredients and intermediaries. Its primary geographic markets are North America, Latin America, Europe, India, and Rest of World.

Granules India (NSE:GRANULES) Headlines

No Headlines